Latest News about CSII
Recent news which mentions CSII
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
February 03, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 03, 2022
From Benzinga
Earnings Scheduled For February 3, 2022
February 03, 2022
From Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
From Benzinga
Cardiovascular Systems, OrbusNeich Scores FDA Approval For Scoreflex Scoring Balloon
January 20, 2022
Tickers
CSII
From Benzinga
The Daily Biotech Pulse: Bausch Files For Eye Health Unit IPO, LumiraDx Antigen Test Can Detect Omicron, Molecular Partners Discloses Fund Stake
January 14, 2022
From Benzinga
Cardiovascular Systems To Develop IVL Technology For Coronary, Peripheral Artery Diseases
January 14, 2022
Tickers
CSII
From Benzinga
Stocks That Hit 52-Week Lows On Friday
January 07, 2022
From Benzinga
Cardiovascular Systems Recalls Wirion Embolic Protection System
November 26, 2021
Tickers
CSII
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2021
November 17, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2021
November 10, 2021
From Benzinga
75 Biggest Movers From Yesterday
November 10, 2021
From Benzinga
Cardiovascular Systems, inc (CSII) Q1 2022 Earnings Call Transcript
November 09, 2021
Tickers
CSII
From Motley Fool
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
From Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
September 23, 2021
From Benzinga
Cardiovascular Systems Expects COVID-19 Impact On Quarterly Revenue
September 22, 2021
Tickers
CSII
From Benzinga
Tickers
CSII
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.